KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Asset Writedowns and Impairment (2016 - 2025)

Cardinal Health's Asset Writedowns and Impairment history spans 17 years, with the latest figure at $14.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 16.67% year-over-year to $14.0 million; the TTM value through Dec 2025 reached $52.0 million, up 20.93%, while the annual FY2025 figure was $53.0 million, 47.22% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $14.0 million at Cardinal Health, up from $13.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $30.0 million in Q4 2022 and bottomed at -$24.0 million in Q2 2023.
  • The 5-year median for Asset Writedowns and Impairment is $13.0 million (2021), against an average of $11.2 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 141.67% in 2022 against a maximum downside of 243.75% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $13.0 million in 2021, then soared by 130.77% to $30.0 million in 2022, then plummeted by 60.0% to $12.0 million in 2023, then changed by 0.0% to $12.0 million in 2024, then increased by 16.67% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Asset Writedowns and Impairment are $14.0 million (Q4 2025), $13.0 million (Q3 2025), and $12.0 million (Q2 2025).